Myocardial damage in COVID-19

Myocardial damage characteristic of a new coronavirus infection is a confirmed risk factor for its severe course and high mortality. There are biomarkers of this condition that correlate with an unfavorable prognosis for the patient. However, information about the problem of myocardial injury in the available literature is not completely systematized. This applies to pathogenesis, differential diagnosis of its causes, routing of patients with acute coronary syndrome. All of the above is very important for choosing the right tactics for examining patients and treating them, which are often time-limited.